Diagnostic services provider Unilabs has selected medical imaging firm Oxipit to provide AI tools for chest x-rays throughout the company's network of European offices, with the initial rollout to occur in Portugal.
The selection of Oxipit’s technology was made following a comprehensive evaluation process, Unilabs said in a statement.
Under this agreement, Oxipit’s CE-marked ChestEye and ChestLink products will be integrated into Unilabs’ radiology workflows.
ChestEye is a full workflow medical imaging suite encompassing a fully automatic computer-aided diagnosis (CAD) platform. ChestLink is a fully autonomous AI medical imaging product that identifies chest x-rays without abnormal findings with 99.9% sensitivity and produces finalized patient reports with no radiologist intervention.
The products support 75 of the most common radiological findings, and they streamline and automate chest x-ray review, enabling radiologists to concentrate on cases with pathologies, according to Oxipit.
![A normal mammogram confirmed by three-year radiologic follow-up illustrates reader-marked regions of interest (ROIs) during (A) unaided (round 1) and (B) artificial intelligence (AI)–assisted (round 2) reading. Each colored dot represents an ROI for recall by a human reader. Readers could mark more than one ROI per case, represented by multiple dots of the same color. During AI-assisted reading, the AI system displayed three visible prompts: two with suspicion of malignancy scores of 35% (left mediolateral oblique [L MLO] and craniocaudal [L CC]) and one with a suspicion of malignancy score of 10% (right craniocaudal [R CC]), shown as polygonal overlays. Without AI, six of 10 readers (60%) marked a false-positive ROI. With AI assistance, this fell to two of 10 (20%). R MLO = right mediolateral oblique.](https://img.auntminnieeurope.com/mindful/smg/workspaces/default/uploads/2026/07/2026-07-14-radiology-mammogram-ai-auto-bias.H0bYO8QlWs.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
